List of Excipients in API nimodipine
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing nimodipine
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Arbor Pharmaceuticals | NYMALIZE | nimodipine | 24338-200 | ALCOHOL | |
| Arbor Pharmaceuticals | NYMALIZE | nimodipine | 24338-200 | GLYCERIN | |
| Arbor Pharmaceuticals | NYMALIZE | nimodipine | 24338-200 | METHYLPARABEN | |
| Arbor Pharmaceuticals | NYMALIZE | nimodipine | 24338-200 | POLYETHYLENE GLYCOL 400 | |
| Arbor Pharmaceuticals | NYMALIZE | nimodipine | 24338-200 | SODIUM PHOSPHATE, DIBASIC | |
| Arbor Pharmaceuticals | NYMALIZE | nimodipine | 24338-200 | SODIUM PHOSPHATE, MONOBASIC | |
| Arbor Pharmaceuticals | NYMALIZE | nimodipine | 24338-200 | WATER | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing nimodipine
Detailed excipient profiles for nimodipine
Excipient focus: ALCOHOL
nimodipine drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Arbor Pharmaceuticals | nimodipine | 24338-200 |
| Azurity Pharmaceuticals Inc | nimodipine | 24338-260 |
| Camber Pharmaceuticals Inc | nimodipine | 31722-039 |
| ANI Pharmaceuticals Inc | nimodipine | 62559-210 |
| >Company | >Ingredient | >NDC |
nimodipine drug variants not containing ALCOHOL
Excipient focus: BUTYL ALCOHOL
nimodipine drug variants containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| ANI Pharmaceuticals Inc | nimodipine | 62559-210 |
| >Company | >Ingredient | >NDC |
nimodipine drug variants not containing BUTYL ALCOHOL
Excipient focus: FD&C RED NO. 40
nimodipine drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| ANI Pharmaceuticals Inc | nimodipine | 62559-210 |
| >Company | >Ingredient | >NDC |
nimodipine drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C YELLOW NO. 6
nimodipine drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | nimodipine | 23155-512 |
| >Company | >Ingredient | >NDC |
nimodipine drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERROSOFERRIC OXIDE
nimodipine drug variants containing FERROSOFERRIC OXIDE
nimodipine drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Arbor Pharmaceuticals | nimodipine | 24338-200 |
| Azurity Pharmaceuticals Inc | nimodipine | 24338-260 |
| Camber Pharmaceuticals Inc | nimodipine | 31722-039 |
| ANI Pharmaceuticals Inc | nimodipine | 62559-210 |
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
nimodipine drug variants containing GELATIN
nimodipine drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Arbor Pharmaceuticals | nimodipine | 24338-200 |
| Azurity Pharmaceuticals Inc | nimodipine | 24338-260 |
| Camber Pharmaceuticals Inc | nimodipine | 31722-039 |
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
nimodipine drug variants containing GLYCERIN
nimodipine drug variants not containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
nimodipine drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Heritage Pharmaceuticals Inc | nimodipine | 23155-108 |
| BIONPHARMA INC | nimodipine | 69452-209 |
| >Company | >Ingredient | >NDC |
nimodipine drug variants not containing HYPROMELLOSES
Excipient focus: LIGHT MINERAL OIL
nimodipine drug variants containing LIGHT MINERAL OIL
| Company | Ingredient | NDC |
|---|---|---|
| ANI Pharmaceuticals Inc | nimodipine | 62559-210 |
| >Company | >Ingredient | >NDC |
nimodipine drug variants not containing LIGHT MINERAL OIL
Excipient focus: MANNITOL
nimodipine drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Heritage Pharmaceuticals Inc | nimodipine | 23155-108 |
| BIONPHARMA INC | nimodipine | 69452-209 |
| >Company | >Ingredient | >NDC |
nimodipine drug variants not containing MANNITOL
Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES
nimodipine drug variants containing MEDIUM-CHAIN TRIGLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | nimodipine | 23155-512 |
| >Company | >Ingredient | >NDC |
nimodipine drug variants not containing MEDIUM-CHAIN TRIGLYCERIDES
Excipient focus: METHYLPARABEN
nimodipine drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Arbor Pharmaceuticals | nimodipine | 24338-200 |
| Azurity Pharmaceuticals Inc | nimodipine | 24338-260 |
| Camber Pharmaceuticals Inc | nimodipine | 31722-039 |
| >Company | >Ingredient | >NDC |
nimodipine drug variants not containing METHYLPARABEN
Excipient focus: PEPPERMINT OIL
nimodipine drug variants containing PEPPERMINT OIL
nimodipine drug variants not containing PEPPERMINT OIL
| Company | Ingredient | NDC |
|---|---|---|
| Arbor Pharmaceuticals | nimodipine | 24338-200 |
| Azurity Pharmaceuticals Inc | nimodipine | 24338-260 |
| Camber Pharmaceuticals Inc | nimodipine | 31722-039 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
nimodipine drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| BIONPHARMA INC | nimodipine | 69452-209 |
| >Company | >Ingredient | >NDC |
nimodipine drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 400
nimodipine drug variants containing POLYETHYLENE GLYCOL 400
nimodipine drug variants not containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| BIONPHARMA INC | nimodipine | 69452-209 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
nimodipine drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Heritage Pharmaceuticals Inc | nimodipine | 23155-108 |
| ANI Pharmaceuticals Inc | nimodipine | 62559-210 |
| BIONPHARMA INC | nimodipine | 69452-209 |
| >Company | >Ingredient | >NDC |
nimodipine drug variants not containing PROPYLENE GLYCOL
Excipient focus: SHELLAC
nimodipine drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | nimodipine | 23155-512 |
| ANI Pharmaceuticals Inc | nimodipine | 62559-210 |
| >Company | >Ingredient | >NDC |
nimodipine drug variants not containing SHELLAC
Excipient focus: SODIUM PHOSPHATE, DIBASIC
nimodipine drug variants containing SODIUM PHOSPHATE, DIBASIC
| Company | Ingredient | NDC |
|---|---|---|
| Arbor Pharmaceuticals | nimodipine | 24338-200 |
| >Company | >Ingredient | >NDC |
nimodipine drug variants not containing SODIUM PHOSPHATE, DIBASIC
Excipient focus: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
nimodipine drug variants containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | nimodipine | 31722-039 |
| >Company | >Ingredient | >NDC |
nimodipine drug variants not containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
Excipient focus: SODIUM PHOSPHATE, MONOBASIC
nimodipine drug variants containing SODIUM PHOSPHATE, MONOBASIC
| Company | Ingredient | NDC |
|---|---|---|
| Arbor Pharmaceuticals | nimodipine | 24338-200 |
| >Company | >Ingredient | >NDC |
nimodipine drug variants not containing SODIUM PHOSPHATE, MONOBASIC
Excipient focus: SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
nimodipine drug variants containing SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | nimodipine | 31722-039 |
| >Company | >Ingredient | >NDC |
nimodipine drug variants not containing SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
Excipient focus: SORBITOL
nimodipine drug variants containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| Heritage Pharmaceuticals Inc | nimodipine | 23155-108 |
| Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | nimodipine | 23155-512 |
| BIONPHARMA INC | nimodipine | 69452-209 |
| >Company | >Ingredient | >NDC |
nimodipine drug variants not containing SORBITOL
Excipient focus: TITANIUM DIOXIDE
nimodipine drug variants containing TITANIUM DIOXIDE
nimodipine drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Arbor Pharmaceuticals | nimodipine | 24338-200 |
| Azurity Pharmaceuticals Inc | nimodipine | 24338-260 |
| Camber Pharmaceuticals Inc | nimodipine | 31722-039 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
nimodipine drug variants containing WATER
nimodipine drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Heritage Pharmaceuticals Inc | nimodipine | 23155-108 |
| Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | nimodipine | 23155-512 |
| Azurity Pharmaceuticals Inc | nimodipine | 24338-260 |
| BIONPHARMA INC | nimodipine | 69452-209 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
